Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: Alzheimer Society Research Program - NI Grants

University of Calgary

$92,500.00

A Fine Balance: Association between Antipsychotic Deprescribing in Long-term Care and Other Medication Prescribing

FY 2020-21

Summary
Long-term care homes in Canada have lowered rates of antipsychotic medication use over the last ten years, but we do not know how this has been done, and studies suggest that other harmful medications are being used instead of antipsychotics. This study will address the question: if an antipsychotic medication is stopped, are persons with dementia in long-term care more likely to receive other harmful medications? This study will use Ontario healthcare data to compare prescriptions of new medications in long-term care residents with dementia who continue on an antipsychotic medication with those who stop an antipsychotic medication. No other studies have directly linked stopping an antipsychotic medication to receiving other, new medications. Using less antipsychotic medications is usually good for the health of those affected by dementia, but it could be resulting in unintended, harmful outcomes in some. We need to identify these to make sure that stopping antipsychotic medications truly improves care for persons with dementia in long-term care.
Program
Operating Grant: Alzheimer Society Research Program - NI Grants
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
448633
Name
Kirkham Julia
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Alzheimer Society of Canada; Alzheimer Society of Canada
Prcname2
Special Cases
Projecttitle
A Fine Balance: Association between Antipsychotic Deprescribing in Long-term Care and Other Medication Prescribing
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$92,500
Cihrequipment2
$0
Programname2
Operating Grant: Alzheimer Society Research Program - NI Grants
Keyworddelim
Alzheimer'S Disease
Abstract
Long-term care homes in Canada have lowered rates of antipsychotic medication use over the last ten years, but we do not know how this has been done, and studies suggest that other harmful medications are being used instead of antipsychotics. This study will address the question: if an antipsychotic medication is stopped, are persons with dementia in long-term care more likely to receive other harmful medications? This study will use Ontario healthcare data to compare prescriptions of new medications in long-term care residents with dementia who continue on an antipsychotic medication with those who stop an antipsychotic medication. No other studies have directly linked stopping an antipsychotic medication to receiving other, new medications. Using less antipsychotic medications is usually good for the health of those affected by dementia, but it could be resulting in unintended, harmful outcomes in some. We need to identify these to make sure that stopping antipsychotic medications truly improves care for persons with dementia in long-term care.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kirkham, Julia
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Aging~ $92,500~ $0~
University of Calgary - $92,500 Grant (2020-21) | Canada Spends